Rika A. Furuta

1.4k total citations
48 papers, 1.1k citations indexed

About

Rika A. Furuta is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Rika A. Furuta has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 13 papers in Infectious Diseases and 10 papers in Virology. Recurrent topics in Rika A. Furuta's work include T-cell and Retrovirus Studies (10 papers), HIV Research and Treatment (10 papers) and Animal Disease Management and Epidemiology (9 papers). Rika A. Furuta is often cited by papers focused on T-cell and Retrovirus Studies (10 papers), HIV Research and Treatment (10 papers) and Animal Disease Management and Epidemiology (9 papers). Rika A. Furuta collaborates with scholars based in Japan and United States. Rika A. Furuta's co-authors include Carol D. Weiss, Carl Wild, Yongkai Weng, Takayuki Miyazawa, Eiji Sato, Fumiya Hirayama, Kazuta Yasui, Jun–ichi Fujisawa, Nobuki Matsuyama and Yoshihiko Tani and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Rika A. Furuta

48 papers receiving 1.0k citations

Peers

Countries citing papers authored by Rika A. Furuta

Since Specialization

Citations

This map shows the geographic impact of Rika A. Furuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika A. Furuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika A. Furuta more than expected).

Fields of papers citing papers by Rika A. Furuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika A. Furuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika A. Furuta. The network helps show where Rika A. Furuta may publish in the future.

Co-authorship network of co-authors of Rika A. Furuta

This figure shows the co-authorship network connecting the top 25 collaborators of Rika A. Furuta. A scholar is included among the top collaborators of Rika A. Furuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika A. Furuta. Rika A. Furuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two cases of Streptococcus dysgalactiae subspecies equisimilis infection transmitted through transfusion of platelet concentrate derived from separate blood donations by the same donor 2023 ·Vox Sanguinis ·(unknown), (unknown), (unknown), Rika A. Furuta, Keiji Matsubayashi, Naoko Goto, Masahiro Satake	1
2	Transfusion‐transmitted HBV infection with isolated anti‐HBs‐positive blood 2023 ·Transfusion ·Masahiro Satake, (unknown), (unknown), Naoko Goto, Tomohiko Sakamoto, (unknown), Rika A. Furuta, Keiji Matsubayashi	6
3	Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study 2023 ·Transfusion ·Rika A. Furuta, Teruhito Yasui, Takeharu Minamitani, Hiroki Akiba, (unknown), (unknown), Kazuta Yasui, (unknown), (unknown), Masahiro Satake	1
4	No evidence of bovine leukemia virus proviral DNA and antibodies in human specimens from Japan 2022 ·Retrovirology ·(unknown), Susumu Saito, (unknown), Ryosuke Matsuura, Shin‐nosuke Takeshima, Kazuyoshi Hosomichi, Yasunobu Matsumoto, Rika A. Furuta, Masami Takei, Yoko Aida	10
5	Novel neutralizing human monoclonal antibodies against tetanus neurotoxin 2021 ·Scientific Reports ·Takeharu Minamitani, (unknown), (unknown), Toshihiro Ito, Hiroki Akiba, Rika A. Furuta, Tsuyoshi Inoue, Kouhei Tsumoto, Masahiro Satake, Teruhito Yasui	10
6	UV light-emitting diode (UV-LED) at 265 nm as a potential light source for disinfecting human platelet concentrates 2021 ·PLoS ONE ·Tomoya Hayashi, Kumiko Oguma, Yoshihiro Fujimura, Rika A. Furuta, Mitsunobu Tanaka, (unknown), (unknown), Takafumi Kimura, Yoshihiko Tani, Fumiya Hirayama, Yoshihiro Takihara, Koki Takahashi	7
7	Mitochondrial damage‐associated molecular patterns as potential proinflammatory mediators in post–platelet transfusion adverse effects 2016 ·Transfusion ·Kazuta Yasui, Nobuki Matsuyama, (unknown), Yoshihiko Tani, Rika A. Furuta, Fumiya Hirayama	44
8	The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins 2015 ·International Journal of Hematology ·Nobuki Matsuyama, Kazuta Yasui, (unknown), Tomoya Hayashi, (unknown), Hiroyuki Ishii, (unknown), Yoshihiko Tani, Rika A. Furuta, Fumiya Hirayama	16
9	Xenotropic Murine Leukemia Virus-Related Virus Proviral DNA Not Detected in Blood Samples Donated in Japan 2012 ·Japanese Journal of Infectious Diseases ·Chieko Matsumoto, (unknown), Rika A. Furuta, Shigeharu Uchida, Masahiro Satake, Kenji Tadokoro	5
10	Establishment of a cell line panel as an alternative source of platelet antigens for a screening assay of anti‐human platelet antibodies 2011 ·Transfusion Medicine ·Tomoya Hayashi, (unknown), (unknown), Kazuta Yasui, Rika A. Furuta, (unknown), Seiji Tanaka, Yasuo Fukumori, Fumiya Hirayama, M. Inoue	18
11	Neonatal alloimmune thrombocytopenia caused by an antibody specific for a newly identified allele of human platelet antigen‐7 2010 ·Transfusion ·(unknown), (unknown), Hiroyuki Ishii, Nobuki Matsuyama, (unknown), Tomoya Hayashi, Rika A. Furuta, Yasuo Fukumori, Fumiya Hirayama, Keiji Yoshimura, (unknown), Susumu Tamai, (unknown)	18
12	Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1 2009 ·Retrovirology ·Shi‐Wen Jiang, Takefumi Inada, Masakazu Tanaka, Rika A. Furuta, Koh Shingu, Jun–ichi Fujisawa	15
13	Possible involvement of heparin-binding protein in transfusion-related acute lung injury 2008 ·Transfusion ·Kazuta Yasui, Rika A. Furuta, Nobuki Matsuyama, Yasuo Fukumori, Takafumi Kimura, Yoshihiko Tani, Hirotoshi Shibata, Fumiya Hirayama	14
14	Establishment of cell lines stably expressing HNA‐1a, ‐1b, and ‐2a antigen with low background reactivity in flow cytometric analysis 2007 ·Transfusion ·Kazuta Yasui, Tôru Miyazaki, Nobuki Matsuyama, (unknown), Rika A. Furuta, Jun–ichi Fujisawa, Yoshihiko Tani, Hirotoshi Shibata, (unknown), Toshiaki Kato, Hisami Ikeda, Fumiya Hirayama	26
15	Real-time analysis of human immunodeficiency virus type 1 Env-mediated membrane fusion by fluorescence resonance energy transfer 2005 ·Microbes and Infection ·Rika A. Furuta, Masao Nishikawa, Jun–ichi Fujisawa	9
16	HIV-1-derived self-inactivating lentivirus vector induces megakaryocyte lineage-specific gene expression 2005 ·Microbes and Infection ·Kazuta Yasui, Rika A. Furuta, Kayoko Matsumoto, Yoshihiko Tani, Jun–ichi Fujisawa	7
17	Capture of an early fusion-active conformation of HIV-1 gp41 1998 ·Nature Structural Biology ·Rika A. Furuta, Carl Wild, Yongkai Weng, Carol D. Weiss	440
18	Inhibition of HIV Replication by Capsid Mutant C6b 1998 ·Biochemical and Biophysical Research Communications ·(unknown), Shinya Iida, Tomoharu Fukumori, Yoshihiko Yamamoto, Meiko Kawamura, Rika A. Furuta, Akio Adachi	10
19	Rev‐dependency of expression of human immunodeficiency virus type 1 gag and env genes 1995 ·FEBS Letters ·Hiroyuki Sakai, Rika A. Furuta, Kenzo Tokunaga, Meiko Kawamura, Masakazu Hatanaka, Akio Adachi	4
20	Functional conversion from HIV-1 Rev to HTLV-1 Rex by mutation 1991 ·Biochemical and Biophysical Research Communications ·Satoshi Kubota, Tetsuya Nosaka, Rika A. Furuta, Masatoshi Maki, Masakazu Hatanaka	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact